IA

ImmunoTargets and Therapy

ImmunoTargets and Therapy is an international open access journal that publishes basic and clinical research on immunology in health and disease, with a focus on the biology of the immune system, immune-based therapies, the immunological basis of disease, and the evidence behind new and existing immunotherapies. Specific topics include immune system biology and pathophysiology, immunological markers of disease, targets for immune-based therapy, immunodiagnostics and immunomonitoring, treatment protocols for immune-mediated diseases, management programs and therapeutic agents, and patient-centered outcomes such as quality of life, adherence, and satisfaction.

Looking to publish in ImmunoTargets and Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Immunology
Impact Factor 4.4
Quartile Q2
Open Access Type Open
eISSN 2253-1556
Invitation Only No
Cost Range An Article Publishing Charge (APC) may be required for open access publication; authors may be able to publish at no cost to themselves or with a reduced APC through institutional or funder agreements, and discounts and waivers may be available for selected countries.

Submission Instructions

ImmunoTargets and Therapy accepts the following article types. Click on an article type to view submission instructions.

Clinical Trial Report

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 300 words. Abstract may be structured or unstructured.
Manuscript Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscript must include the clinical trial number and registration date, usually in the abstract and methods sections, and provide 3–6 keywords.
References References requirements are not specified.
Figures & Tables Figures must be provided separate from the manuscript, tables must be provided in editable format, and pasted figures or image-based tables are not allowed. All figures and tables must be cited in the text, and figure legends and table keys or explanatory notes must be included when needed to explain labels, symbols, abbreviations, or formatting.
Reformat to ImmunoTargets and Therapy using Livewrite Premium

Original Research

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required for Original Research. Abstract must not exceed 300 words. Abstract must be structured.
Manuscript Manuscript typically includes Abstract, Introduction, Methods, Results, Discussion, and Conclusion sections. Manuscript must include 3–6 keywords.
References References requirements are not specified.
Figures & Tables Figures must be provided separate from the manuscript, and tables must be provided in an editable format rather than as images. Figures and tables must each be cited in the text, with figure legends and table legends or footnotes providing explanatory keys when needed.
Reformat to ImmunoTargets and Therapy using Livewrite Premium

Registered Report

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 300 words.
Manuscript Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscript must include 3–6 keywords.
References References requirements are not specified.
Figures & Tables Figures must be provided separate from the manuscript, and tables must be provided in their original editable format rather than as images. All figures and tables must be cited in the text, figures must not be pasted into the manuscript, and tables must not be supplied as images.
Reformat to ImmunoTargets and Therapy using Livewrite Premium

Review

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 300 words.
Manuscript Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscript must include 3–6 keywords.
References References requirements are not specified.
Figures & Tables Figures must be provided separate from the manuscript, and tables must be provided in their original editable format rather than as images. Figures and tables must be cited in the text, and figure legends and table legends must include explanatory keys or notes when symbols, abbreviations, or formatting indicate significant data.
Reformat to ImmunoTargets and Therapy using Livewrite Premium

Case Report

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 300 words. Abstract may be structured or unstructured.
Manuscript Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscript must include 3–6 keywords.
References References requirements are not specified.
Figures & Tables Figures must be uploaded separately from the manuscript, and tables must be provided in their original editable format. Figures must not be pasted into the manuscript, and tables must not be supplied as images.
Reformat to ImmunoTargets and Therapy using Livewrite Premium

Case Series

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required and must not exceed 300 words. Abstract must be no more than 300 words.
Manuscript Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscript must include 3–6 keywords.
References References requirements are not specified.
Figures & Tables Figures must be provided separate from the manuscript, and tables must be provided in an editable format rather than as images. Figures and tables must each be cited in the text, and table legends must appear above each table while figure legends begin with the figure number.
Reformat to ImmunoTargets and Therapy using Livewrite Premium

Letter To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Letters To The Editor are limited to 1500 words.
References Letters To The Editor must contain no more than 15 references, including one reference to the article under discussion.
Figures & Tables Letters To The Editor must not contain figures or tables.
Reformat to ImmunoTargets and Therapy using Livewrite Premium

Rapid Communication

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 300 words.
Manuscript Rapid Communication manuscripts must be up to 2000 words. Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscript must include 3–6 keywords.
References References requirements are not specified.
Figures & Tables Figures must be provided separately from the manuscript, and tables must be provided in an editable format rather than as images.
Reformat to ImmunoTargets and Therapy using Livewrite Premium

Research Letter

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not be included.
Manuscript Research Letter text must not exceed 2,000 words. Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Keywords must not be included.
References Research Letters must not exceed 7 references.
Figures & Tables Research Letters may include up to 2 tables or figures, including photographs or images. Figures must be provided separate from the manuscript, and the manuscript must not contain pasted figures.
Reformat to ImmunoTargets and Therapy using Livewrite Premium

Short Report

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 300 words.
Manuscript Short Reports must be up to 2000 words. Manuscripts must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscripts must include 3–6 keywords.
References References requirements are not specified.
Figures & Tables Figures must be provided separate from the manuscript, and tables must be provided in their original editable format rather than as images. All figures and tables must be cited in the text, with figure legends beginning with the figure number and table legends presented above each table.
Reformat to ImmunoTargets and Therapy using Livewrite Premium

Meeting Report

Cover Letter Cover Letter requirements are not specified.
Abstract A short unstructured abstract is required. Abstract must not exceed 300 words. Abstract must be unstructured. Abstract must state the name, location (city and state or country), dates, and nature of the meeting.
Manuscript Manuscript must not exceed 2500 words. Body may include subsections with short headings. If speakers are mentioned, each speaker’s full name, institution, city, and country must be provided, and a URL to the meeting abstract collection should be included if such a collection was published.
References Reference list must not be included.
Figures & Tables Figures must be uploaded separately from the manuscript. Figures must not be pasted into the manuscript, and tables must be supplied in editable format rather than as images.
Reformat to ImmunoTargets and Therapy using Livewrite Premium

Recent Publications

Integrin alpha8beta1 is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple Myeloma

Suiping Liu, Jieying Wu, Jiayu Liu, Kangxiu Wu, Yanyan Huang, Suxia Geng, Yulian Wang, Jianyu Weng, Xin Du, Peilong Lai

10.2147/itt.s605729
View Publication

The Immune Architecture of Eosinophilic Esophagitis: Mechanisms, Therapeutic Targets, and Precision Management

Luisa Bertin, Federico Caldart, Alberto Barchi, Niccolò Seregni, Andrea Pasta, Francesco Calabrese, Elisa Marabotto, Amir Mari, Amir Farah, Emma Sirinic, Andrea Sorge, Matteo Ghisa, Javier Chahuán, Vincenzo Savarino, Edoardo Vincenzo Savarino

10.2147/itt.s510865
View Publication

Comprehensive Review of Immunotherapy in Colorectal Cancer: From Mechanisms to Nursing Interventions

Qiuyu Zhu, Yongwei Lai, Jie Zhao, Zhihong Zhang, Xiaoli Cui, Mengyuan Kou

10.2147/itt.s603959
View Publication

Identification of Prognostic Clinical Features in Grade 4 Immune-Related Adverse Events: A Triangulation Study

Yulin Wu, Junyao Chen, Sijia Tian, Zhaojie Lin, Yong Li, Cuihan Wang, Qianying Lu, Lu Lu, Yanmei Zhao

10.2147/itt.s609130
View Publication

Advances in the Management of Mediator-Related Symptoms in Non-Advanced Systemic Mastocytosis

Theo Gülen, Vito Sabato

10.2147/itt.s609692
View Publication

Frequently asked questions

How long does it take to publish?

Is a cover letter required?

A point-by-point covering letter is required when submitting a revised manuscript after first editorial review.

Reformat to ImmunoTargets and Therapy using Livewrite Premium

What are the publication costs?

An Article Publishing Charge (APC) may be required for publication. Authors may be able to publish at no cost to themselves or with a reduced APC through institutional or funder agreements, and discounts and waivers may be available for selected countries.

Reformat to ImmunoTargets and Therapy using Livewrite Premium

Research Topics

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Immune Cell Function and Interaction CAR-T cell therapy research Immune cells in cancer Monoclonal and Polyclonal Antibodies Research Ferroptosis and cancer prognosis Hepatocellular Carcinoma Treatment and Prognosis Immune Response and Inflammation T-cell and B-cell Immunology Lymphoma Diagnosis and Treatment Cholangiocarcinoma and Gallbladder Cancer Studies Immunodeficiency and Autoimmune Disorders Peripheral Neuropathies and Disorders Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Diabetes and associated disorders Chronic Lymphocytic Leukemia Research SARS-CoV-2 and COVID-19 Research Systemic Lupus Erythematosus Research Single-cell and spatial transcriptomics Autoimmune Neurological Disorders and Treatments Tuberculosis Research and Epidemiology Multiple Sclerosis Research Studies Virus-based gene therapy research

Related Journals

II
International Immunopharmacology Elsevier BV
CE
Clinical Epidemiology Dove Medical Press
BM
Bone Marrow Transplantation Springer Nature
CI
Cancer Immunology Immunotherapy Springer Science+Business Media
JO
Journal of Inflammation Research Dove Medical Press
AO
Annals of Allergy Asthma & Immunology Elsevier BV